Dopaminergic Changes in the Basal Ganglia A Generalized Phenomenon of Aging in Mammalsa

Annals of the New York Academy of SciencesVolume 515, Issue 1 p. 145-160 Dopaminergic Changes in the Basal Ganglia A Generalized Phenomenon of Aging in Mammalsa DAVID G. MORGAN, DAVID G. MORGAN Andrus Gerontology Center and Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-0191Search for more papers by this authorCALEB E. FINCH, CALEB E. FINCH Andrus Gerontology Center and Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-0191Search for more papers by this author DAVID G. MORGAN, DAVID G. MORGAN Andrus Gerontology Center and Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-0191Search for more papers by this authorCALEB E. FINCH, CALEB E. FINCH Andrus Gerontology Center and Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-0191Search for more papers by this author First published: January 1988 https://doi.org/10.1111/j.1749-6632.1988.tb32978.xCitations: 60 a This research was supported by Grant No. AG-05142 to C. E. Finch. D. G. Morgan was supported by a fellowship from the John Douglas French Foundation for Alzheimer's Disease. C. E. Finch is the ARCO/William F. Keischnick Professor in the Neurobiology of Aging. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Lindvall, O. & A. Bjorklund 1983. Dopamine and norepinephrine containing neuron systems. Their anatomy in the rat brain. In Chemical Neuroanatomy. P. C. Emson, Ed.: 229–255. Raven Press. New York . 2 Snyder, S. H. 1976. The dopamine hypothesis of schizophrenia: Focus on the dopamine receptor. Am. J. Psychiatry 133: 197–202. 3 Seeman, P. 1980. Brain dopamine receptors. Pharmacol. Rev. 32: 229–313. 4 Bernheimer, H., W. Birkmayer, O. Hornykiewicz, K. Jellinger & F. Seitelberg 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20: 415–455. 5 Demarest, K. T., G. D. Riegle & K. E. Moore 1980. Characteristics of dopaminergic neurons in the aged male rat. Neuroendocrinology 31: 222–227. 6 Govoni, S., P. Loddo, P. F. Spano & M. Trabucchi 1977. Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res. 138: 565–570. 7 Cooper, J. R., F. E. Bloom & R. H. Roth 1985. The Biochemical Basis of Neuropharmacology. Oxford University Press. London/New York . 8 Stoof, J. C. & J. W. Kebabian 1984. Two dopamine receptors: Biochemistry, physiology, and pharmacology. Life Sci. 35: 2281–2296. 9 Stoof, J. C., J. W. Kebabian 1981. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294: 366–368. 10 Onali, P., M. C. Olianas & G. L. Gessa 1984. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. Eur. J. Pharmacol. 99: 127. 11 Bacopoulos, N. G. 1983. (3H)Dopamine binds to D-1 and D-2 receptors in rat striatum. Eur. J. Pharmacol. 87: 353–356. 12 Seeman, P., C. Ulpian, K. A. Wregget & J. W. Wells 1984. Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: Analysis and examples. J. Neurochem. 43: 221–227. 13 Bird, E. D. & L. L. Iversen 1974. Huntington's chorea: Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97: 457–472. 14 Robinson, D. S., R. L. Sourkes, A. Nies, L. S. Harris, S. Spector, D. L. Bartlett & I. S. Kaye 1977. Monoamine metabolism in human brain. Arch. Gen. Psychiatry 34: 89–92. 15 MacKay, A. V. P., L. L. Iverson, M. Rossor, E. Spokes, E. Bird, A. Arregui, I. Creese & S. Snyder 1982. Increased brain dopamine and dopamine receptors in schizophrenia. Arch. Gen. Psychiatry 39: 991–997. 16 Adolfsson, R., C. G. Gottfries, B. E. Roos, B. E. Roos & B. Winblad 1979. Changes in brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry 135: 216–223. 17 Carlsson, A. 1981. Aging and brain neurotransmitters. In Funktionsstorurgen des Gehirns im Alter. D. Piatt, Ed.: 67–81. Schattauer. Stuttgart . 18 McGeer, P. L., E. G. McGeer, & J. S. Suzuki 1977. Aging and extrapyramidal function. Arch. Neurol. Chicago 34: 33–35. 19 McGeer, E. G., P. L. McGeer, & J. A. Wada 1971. Distribution of tyrosine hydroxylase in human and animal brain. J. Neurochem. 18: 1647–1658. 20 McGeer, P. L. & E. G. McGeer 1976. Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson's disease and Huntington's chorea. J. Neurochem. 26: 65–76. 21 Wong, D. F., H. N. Wagner, R. F. Dannals, J. M. Links, J. J. Frost, H. T. Ravert, A. A. Wilson, A. E. Rosenbaum, A. Gjedde, K. H. Douglass, J. D. Petronis, M. F. Folstein, J. K. Tuong, H. D. Burns & M. J. Kuhar 1984. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226: 1393–1396. 22 Morgan, D. G., P. C. May & C. E. Finch 1986. Dopamine and serotonin systems in human and rodent brain: Effects of age and degenerative disease. J. Am. Geriatr. Soc. 35: 334–345. 23 Bzowej, N. H. & P. Seeman 1985. Age and dopamine D1 and D2 receptors in human brain. Neurosci. Abstr. 11: 889 (#260.5). 24 Severson, J. A. & C. E. Finch 1980. Reduced dopaminergic binding during aging in the rodent striatum. Brain Res. 192: 147–162. 25 Randall, P. K., J. A. Severson & C. E. Finch 1981. Aging and the regulation of striatal dopaminergic mechanisms in mice. J. Pharmacol. Exp. Ther. 219: 690–700. 26 Algeri, S., G. Achilli, M. Cimino, C. Perego, F. Ponzio & G. Vantini 1982. Study on some compensatory responses of dopaminergic system in aging rats. Exp. Brain Res. Suppl. 5: 146–152. 27 Roth, G. S., D. K. Ingram & J. A. Joseph 1984. Delayed loss of striatal dopamine receptors during aging of dietarily restricted rats. Brain Res. 300: 27–32. 28 Joyce, J. N., S. K. Loeschen, D. W. Sapp & J. F. Marshall 1986. Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiography. Brain Res. 378: 158–163. 29 Thal, L. J., S. G. Horowitz, B. Dvorkin & M. H. Makman 1980. Evidence for loss of brain [3H]spiroperidol and [3H]ADTN binding sites in rabbit brain with aging. Brain Res. 152: 626–632. 30 Severson, J. A. & P. K. Randall 1985. D-2 dopamine receptors in aging mouse straitum: Determination of high-and low-affinity agonist binding sites. J. Pharmacol. Exp. Ther. 233: 361–368. 31 Morgan, D. G. & C. E. Finch 1986. The role of serotonin deficiency in Alzheimer's Disease. Bull. Clin. Neurosci.In press. 32 Morgan, D. G., P. C. May & C. E. Finch 1986. Neurotransmitter receptors in normal human aging and Alzheimer's disease. In Receptors and Ligands in Psychiatry and Neurology. A. K. Sen, & T. Y. Lee, Eds. In press. 33 Bertler, A. 1961. Occurrence and localization of catecholamines in the human brain. Acta Physiol. Scand. 51: 97–107. 34 Carlsson, A. & B. Winblad 1976. The influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J. Neural Transm. 38: 271–276. 35 Reiderer, P. & S. T. Wuketich 1976. Time course of nigrostriatal degeneration in Parkinson's disease. J. Neural Transm. 38: 277–301. 36 Hornykiewicz, O. 1983. Dopamine changes in the aging human brain: Functional considerations. In Aging, Vol. 23: Aging Brain and Ergot Alkaloids. A. Agnoli et al., Eds.: 9–14. Raven Press. New York . 37 Severson, J. A., J. Marcusson, B. Winblad & C. E. Finch 1982. Age-correlated loss of dopaminergic binding sites in human basal ganglia. J. Neurochem. 39: 1623–1631. 38 Joseph, J. A., R. E. Berger, B. T. Engel & G. S. Roth 1978. Age-related changes in the nigrostriatum: A behavioral and biochemical analysis. J. Gerontol. 33: 643–649. 39 Ponzio, F., N. Brunello & S. Algeri 1978. Catecholamine synthesis in brain of aging rat. J. Neurochem. 30: 1617–1620. 40 Austin, J. H., E. Connole, K. Doubravka & J. Collins 1978. Studies in aging of the brain. V. Reduced norepinephrine, dopamine, and cyclic amp in rat brain with advancing age. Age 1: 121–124. 41 Joseph, J. A., C. Filburn, S. P. Tzankoff, J. M. Thompson & B. T. Engel 1980. Age-related neostriatal alterations in the rat: Failure of L-DOPA to alter behavior. Neurobiol. Aging 1: 119–125. 42 Hirschorn, I. D., M. H. Makman & N. S. Sharpless 1982. Dopamine receptor sensitivity following nigrostriatal lesions in the aged rat. Brain Res. 234: 257–368. 43 Ponzio, F., G. Calderini, G. Lomuscio, G. Vantini, G. Toffano & S. Algeri 1982. Changes in monoamine and their metabolite levels in some brain regions of aged rats. Neurobiol. Aging 3: 23–39. 44 Strong R., T. Samorajski & Z. Gottesfeld 1982. Regional mapping of neostriatal neurotransmitter systems as a function of aging. J. Neurochem. 39: 831–836. 45 Marshall, J. F., M. C. Drew & K. A. Neve 1983. Recovery of function after mesotelencephalic dopaminergic injury in senescence. Brain Res. 259: 249–260. 46 Ponzio, F., G. Achilli, G. Calderini, P. Ferretti, C. Perego, G. Toffano & S. Algeri 1984. Depletion and recovery of neuronal monoamine storage in rats of different ages treated with reserpine. Neurobiol. Aging 5: 101–104. 47 Timiras, P. S., D. B. Hudson & P. E. Segall 1984. Lifetime brain serotonin: Regional effects of age and precursor availability. Neurobiol. Aging 5: 235–242. 48 Finch, C. E. 1973. Catacholamine metabolism in the brains of aging male mice. Brain Res. 52: 261–276. 49 Papavasiliou, P. S., S. T. Miller, L. S. Thal, L. J. Nerder, G. Houlihan, S. N. Rao & J. M. Stevens 1981. Age-related motor and catecholamine alterations in mice on levodopa supplemented diet. Life Sci. 28: 2945–2952. 50 Severson, J. A., H. H. Osterburg, & C. E. Finch 1981. Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice. Neurobiol. Aging 2: 193–197. 51 Osterburg, H. H., H. G. Donahue, J. A. Severson, & C. E. Finch 1981. Catecholamine levels and turnover during aging in brain regions of male C57BL/6J mice. Brain Res. 224: 337–352. 52 Makman, M. H., E. L. Gardner, L. J. Thal, I. D. Hirschhorn, T. F. Seeger & G. Bhargava 1980. Central monoamine receptor systems. Influence of aging, lesion, and drug treatment. In Neural Regulatory Mechanisms during Aging, p. 91–127. Alan R. Liss. New York . 53 Sladek, J. R. & C. D. Sladek, 1979. Relative quantitation of monoamine histofluorescence in young and old non-human primates. Parkinson's Disease II, Aging and Neuroendocrine Relationships. C. E. Finch, D. E. Potter, & A. D. Kenny, Eds.: 241–250. Plenum. New York . 54 Goldman-Rakic, P. S. & R. M. Brown 1981. Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6: 177–187. 55 McGeer, E. G., H. C. Fibiger, P. L. McGeer & V. Wickson 1971. Aging and brain enzymes. Exp. Gerontol. 6: 391–396. 56 Reis, D. J., R. A. Ross & T. H. Joh 1977. Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse. Brain Res. 136: 465–474. 57 O'Boyle, K. M. & J. L. Waddington 1984. Loss of rat striatal dopamine receptors with aging is selective for D-2 but not D-1 sites: Association with increased nonspecific binding of the D-1 ligand [3H]piflutixol. Eur. J. Pharmacol. 105: 171–174. 58 Giorgi, O., G. Calderini, G. Toffano & G. Biggio 1986. D-1 dopamine receptors labeled with [3H]SCH-23390: Decrease in the striatum of aged rats. Neurobiol. Aging. In press. 59 Govoni, S., P. F. Spano & M. Trabucchi 1978. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during aging. J. Pharm. Pharmacol. 30: 448–449. 60 Govoni, S., M. Memo, L. Saiani, P. F. Spano & Trabucci 1980. Impairment of brain neurotransmitter receptors in aged rats. Mech. Aging Dev. 12: 39–46. 61 Memo, M., L. Lurchi, P. F. Spano & M. Trabucchi 1980. Aging process affects a single class of dopamine receptors. Brain Res. 202: 488–492. 62 Misra, C. H., H. Shelat, & R. C. Smith 1981. Influence of age on the effects of chronic fluphenazine on receptor binding in rat brain. Eur. J. Pharmacol. 76: 317–324. 63 Joseph, J. A., C. R. Filburn & G. S. Roth 1981. Development of dopamine receptor denervation supersensitivity in the neostriatum of the senescent rat. Life Sci. 29: 575–584. 64 De Blasi, A. & T. Mennini 1982. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats. Brain Res. 242: 361–364. 65 Marquis, J. K., A. S. Lippa & R. W. Pelham 1982. Dopamine receptor alterations with aging in mouse and rat corpus striatum. Biochem. Pharmacol. 30: 1876–1878. 66 Misra, C. H., H. Shelat & R. C. Smith 1982. Age affects dopamine receptor changes during chronic administration of fluphenazine. Eur. J. Pharmacol. 85: 343–346. 67 Cimino, M., G. Curatola, C. Pezzoli, G. Stramentinoli, G. Vantini, & S. Algeri 1983. Age-related modification of dopaminergic and B-adrenergic receptor system: Restoration of normal activity by modifying membrane fluidity with S-adenosyl methionine. Aging 23: 79–86. 68 Joseph, J. A., R. T. Bartus, D. Clody, D. Morgan, C. Finch, B. Beer & S. Sesack 1983. Psychomotor performance in the senescent rodent: Reduction of deficits via striatal dopamine receptor up-regulation. Neurobiol. Aging 4: 313–319. 69 Levtn, P., M. Haji, J. A. Joseph & G. S. Roth 1983. Effect of aging on prolactin regulation of rat striatal dopamine receptor concentrations. Life Sci. 32: 1743–1749. 70 Missale, C., S. Govoni, L. Castelletti, P. F. Spano & M. Trabucchi 1983. Brain neurotransmitter changes in brains of aged rats. Aging 23: 15–22. 71 Henry J. M. & G. S. Roth 1984. Effect of aging on recovery of striatal dopamine receptors following n-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade. Life Sci. 35: 899–904. 72 Randall, P. K., J. A. Severson, S. M. Hurd & W. O. McClure 1985. Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice. Brain Res. 333: 85–95. 73 Severson J. A. & P. K. Randall 1985. D-2 dopamine receptors in aging mouse striatum: Determination of high-and low-affinity agonist binding sites. J. Pharmacol. Exp. Ther. 233: 361–368. 74 Levin, P., J. K. Janda, J. A. Joseph, D. K. Ingram & G. S. Roth 1981. Dietary restriction retards the age-associated loss of rat striatal dopaminergic receptors. Science 214: 561–562. 75 Walker, J. B. & J. P. Walker 1973. Properties of adenylate cyclase from senescent rat brain. Brain Res. 54: 391–396. 76 Puri, S. K. & L. Volicer 1977. Effects of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum. Mech. Aging Dev. 6: 53–58. 77 Schmidt, M. J. & J. F. Thornberry 1978. Cyclic AMP and cyclic GMP accumulation in vitro in brain regions from young, old and aged rats. Brain Res. 139: 159–177. Citing Literature Volume515, Issue1Central Determinants of Age‐Related Declines in Motor FunctionJanuary 1988Pages 145-160 ReferencesRelatedInformation